United States · FDA National Drug Code directory
Prochlorperazine Edisylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68083-435_868ffb82-fd9b-4157-9e2c-1b76191ac1aa
- Product NDC
- 68083-435
- Form
- INJECTION
- Composition / generic term
- Prochlorperazine Edisylate
- Labeler
- Gland Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210922
- Source listing expiry
- 20261231
Source-listed ingredients
- PROCHLORPERAZINE EDISYLATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (68083-435-10) / 2 mL in 1 VIAL (68083-435-01) · 68083-435-10
- 25 VIAL in 1 CARTON (68083-435-25) / 2 mL in 1 VIAL (68083-435-01) · 68083-435-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →